(Q33742983)

29 July 2017

1 reference

title

Screening for cancer: future potential (English)

1 reference

29 July 2017

Cuzick J

1

1 reference

29 July 2017

1 May 1999

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

35

1 reference

29 July 2017

5

1 reference

29 July 2017

685-692

1 reference

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Accelerated decline in cervical cancer mortality in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Improved cervical smear assessment using antibodies against proteins that regulate DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Human papillomavirus testing in primary cervical screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Human papillomavirus DNA after treatment of cervical dysplasia: low prevalence in normal cytologic smears

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Breast cancer screening with mammography: overview of Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Electropotential measurements as a new diagnostic modality for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Measurement of the electrical bio-impedance of breast tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

The luteal heat cycle of the breast in health

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

An electronic approach to the detection of pre-cancer and cancer of the uterine cervix: a preliminary evaluation of Polarprobe.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Randomised study of screening for colorectal cancer with faecal-occult-blood test

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Evaluation of new occult blood tests for detection of colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Screening sigmoidoscopy and colorectal cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Prevention of colorectal cancer by once-only sigmoidoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Modalities available for screening for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Transabdominal ultrasound screening for early ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Cytologic screening for esophageal cancer: results from 12,877 subjects from a high-risk population in China

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

HPV testing in primary screening of older women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

The prevention of invasive cancer of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Multiphasic Health Checkup Evaluation: a 16-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900070-2

7 January 2021

10.1016/S0959-8049(99)00070-2

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10505025